With advances in technology and genetics, Feinberg and Northwestern investigators are conducting basic science research to understand just how the retina works in concert with the brain.
A recent study revealed how sensory processing centers communicate with one another within brain, with implications for neurodegenerative disease.
Northwestern Medicine scientists have mapped a brain circuit that sends information from the hippocampus and thalamus to the retrosplenial cortex, an area of the brain involved in memory formation.
According to a recent study, a novel nanoparticle-based drug repaired neurons and improved microvasculature in a mouse model of spinocerebellar ataxia 1, a degenerative disease that affects the cerebellum.
Abnormal activation of a small population of neurons may contribute to motor learning and motor function deficits in patients with Parkinson’s disease, according to a recent study.
Northwestern Medicine scientists have discovered that amacrine cells produce nitric oxide, a neuromodulator that regulates blood dilation, in a recently published study.
Northwestern Medicine scientists have discovered a mechanism for rapid, fine adjustments in motor plans, according to a recent study.
In a study published in Nature, Northwestern Medicine scientists have demonstrated that a gene is critical for the development of the ear’s outer hair cells, which has important implications for hearing loss treatments.
Scientists have shown they can predict which chronic pain patients will respond to a placebo pill based on brain anatomy and psychological characteristics.
In a study published in Nature Neuroscience, Northwestern Medicine scientists demonstrated that subtypes of dopamine neurons have distinct projection patterns.
Treating mice with isradipine, a calcium channel blocker, prevented formation of toxic compounds that can cause Parkinson’s disease symptoms, according to a recent Northwestern Medicine study.
Northwestern Medicine scientists used an innovative technique to measure electrical activity in ALS neurons, finding changes in excitability that indicated disease, according to a study published in Stem Cell Reports.
Feinberg met its goal of raising $10 million for the newly renamed Mesulam Cognitive Neurology and Alzheimer’s Disease Center, naming the Center after its director, M. Marsel Mesulam, MD.
Northwestern scientists restored chemical balance to certain brain cells in mouse models, reversing mechanisms that may be responsible for sensory hypersensitivity in patients with autism.
The newly-launched Center for Autism and Neurodevelopment is a translational science hub that aims to investigate the neurobiology of autism and facilitate the development of new treatments.
Northwestern Medicine scientists have uncovered how DNA methylation triggers stem cells to transform into more specialized neuronal cells.
Northwestern Medicine scientists have demonstrated a new method that helps to pinpoint which genetic variants might be most important in the development of schizophrenia and related disorders.
Northwestern Medicine scientists and co-authors defined a role for the WAVE1 protein in the cellular mechanisms behind cocaine addiction.
New Northwestern Medicine research shows how astrocytes, a type of cell in the brain, may play a role in regulating a pathway that is overactive in Parkinson’s disease.
By targeting a hub of schizophrenia-related genes, Northwestern Medicine scientists were able to correct a disease-related alteration in mouse model neurons.
Certain anatomical properties of the brain – not the initial injury – determine most of a patient’s risk of developing chronic pain, according to a new study.
Genetic mutations that cause neuropsychiatric disorders may make synapses smaller and weaker, according to a new Northwestern Medicine study.
Northwestern Medicine scientists mapped brain circuitry associated with addiction and reward, and found that smoking affects the way the brain relates and responds to pain. The findings could lead to targeted therapies for chronic pain sufferers.
Northwestern Medicine scientists have proven an old therapeutic focus for Huntington's disease wrong, and they propose a new one in its place.
The experimental drug prolonged the lifespan in a mouse model of accelerated aging by inhibiting a protein that plays a key role in the process.
Tanya Simuni, MD, was awarded a grant from the National Institutes of Health to conduct a $16 million phase III study of the safety and efficacy of the drug isradipine as a potential neuroprotective agent in Parkinson's disease.